First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Reaches New 12-Month High – Should You Buy?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) shares reached a new 52-week high on Tuesday . The stock traded as high as GBX 1,698.30 ($21.85) and last traded at GBX 1,698.30 ($21.85), with a volume of 316 shares traded. The stock had previously closed at GBX 1,676.05 ($21.57).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Down 0.2 %

The company has a quick ratio of 9.27, a current ratio of 9.42 and a debt-to-equity ratio of 0.04. The business has a 50-day simple moving average of GBX 1,595.76 and a 200-day simple moving average of GBX 1,533.68. The stock has a market cap of £4.99 billion and a P/E ratio of -1,536.09.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.